Plasminogen activator regulation in osteoblasts: Parathyroid hormone inhibition of type‐1 plasminogen activator inhibitor and its mRNA
Authors:
- 1 August 1992
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 152 (2) , 346-355
Abstract
In order to determine the mechanism by which parathyroid hormone (PTH) stimulates plasminogen activator (PA) activity in rat osteoblasts, we investigated the effect of human PTH(1–34) [hPTH(1–34)] on the synthesis of mRNAs for tissue‐type PA (tPA), urokinase‐type PA (uPA), and PA inhibitor‐1 (PAI‐1), and on release of PA activity and PAI‐1 protein in both normal rat calvarial osteoblasts and UMR 106‐01 osteogenic sarcoma cells. hPTH(1–34) (0.25–25 nM) decreased PAI‐1 mRNA and protein, and increased PA activity in both cell types in a dose‐dependent manner with ED50 of about 1 nM for both responses. Forskolin and isobutylmethylxanthine also stimulated PA activity and decreased PAI‐1 protein and mRNA in both cell types. hPTH(1–34) did not show any consistent effect on tPA and uPA mRNA in calvarial osteoblasts, but a modest (two‐fold) increase of both mRNAs was observed in UMR 106‐01 cells treated with 25 nM hPTH(1–34). However, when protein synthesis was inhibited with 100 μM cycloheximide, the increase of tPA and uPA mRNA by hPTH(1–34) was enhanced in UMR 106‐01 cells and became evident in calvarial osteoblasts. Fibrin autography also revealed that hPTH(1–34) increases tPA and uPA activity, especially after cycloheximide treatment in UMR 106‐01 cells. These results strongly suggest that PTH increases PA activity predominantly by decreasing PAI‐1 protein production through a cyclic adenosine monophosphate (cAMP)‐dependent mechanism in rat osteoblasts. The reduction of PAI‐1 protein by PTH results in enhanced action of both tPA and uPA, and would contribute to the specific roles of these PAs in bone.Keywords
This publication has 49 references indexed in Scilit:
- Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblastsEndocrinology, 1992
- Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotidesMolecular Endocrinology, 1992
- Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.Journal of Cell Biology, 1990
- Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cellsMolecular and Cellular Endocrinology, 1990
- Modulation of levels of messenger RNA for tissue-type plasminogen activator in rat Sertoli cells, and levels of messenger RNA for plasminogen activator inhibitor in testis peritubular cellsMolecular and Cellular Endocrinology, 1990
- Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone.Journal of Cell Biology, 1989
- Cloning and Characterization of a cDNA for Rat Tissue-Type Plasminogen ActivatorDNA, 1988
- Hormonal regulation of extracellular plasminogen activators and Mr ∼ 54000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodiesMolecular and Cellular Endocrinology, 1986
- Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormonesBiochemical and Biophysical Research Communications, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970